150 related articles for article (PubMed ID: 29191042)
21. Preparation, Characterization, and In Vitro/In Vivo Evaluation of 3-O-β-D-Galactosylated Resveratrol-Loaded Polydopamine Nanoparticles.
Wang B; Shan X; Lv S; Zha L; Zhang C; Dong Q; Chen W
AAPS PharmSciTech; 2021 Aug; 22(7):220. PubMed ID: 34405290
[TBL] [Abstract][Full Text] [Related]
22. Potential of Cationic-Polymeric Nanoparticles for Oral Delivery of Naringenin: In Vitro and In Vivo Investigations.
Chaurasia S; Patel RR; Vure P; Mishra B
J Pharm Sci; 2018 Feb; 107(2):706-716. PubMed ID: 29031951
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of polymeric nanoparticles containing linoleic acid-SN38 (LA-SN38) conjugate in a murine model of colorectal cancer.
Cheng G; Zhang X; Chen Y; Lee RJ; Wang J; Yao J; Zhang Y; Zhang C; Wang K; Yu B
Colloids Surf B Biointerfaces; 2019 Sep; 181():822-829. PubMed ID: 31247407
[TBL] [Abstract][Full Text] [Related]
24. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
[TBL] [Abstract][Full Text] [Related]
25. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
26. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F
J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance.
Chen Q; Luo L; Xue Y; Han J; Liu Y; Zhang Y; Yin T; Wang L; Cun D; Gou J; He H; Tang X
Acta Biomater; 2019 Jul; 92():205-218. PubMed ID: 31071475
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
[TBL] [Abstract][Full Text] [Related]
30. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
31. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Xiong H; Wu Y; Jiang Z; Zhou J; Yang M; Yao J
J Colloid Interface Sci; 2019 Feb; 536():135-148. PubMed ID: 30366179
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
[TBL] [Abstract][Full Text] [Related]
33. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q
Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936
[TBL] [Abstract][Full Text] [Related]
34. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
35. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
36. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting.
Liu H; Xu H; Jiang Y; Hao S; Gong F; Mu H; Liu K
Int J Nanomedicine; 2015; 10():6395-410. PubMed ID: 26504386
[TBL] [Abstract][Full Text] [Related]
38. Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability.
Zhang HY; Firempong CK; Wang YW; Xu WQ; Wang MM; Cao X; Zhu Y; Tong SS; Yu JN; Xu XM
Acta Pharmacol Sin; 2016 Jun; 37(6):834-44. PubMed ID: 27133301
[TBL] [Abstract][Full Text] [Related]
39. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
40. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
